Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.47 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.47 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | EYA2 | O00167 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | BLM | P54132 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28596943 | 0.90 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL27465344 | 0.89 | TSHR (0.38) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL1493219 | 0.89 | GLRA1 (0.38) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL21955799 | 0.85 | GLRA1 (0.39) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL28216386 | 0.84 | GLRA1 (0.38) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL2435231 | 0.82 | HDAC6 (0.37) | GLRA1SLC6A9OR51E2KDM4EKMT2A | |
| SCHEMBL7633350 | 0.82 | GLRA1 (0.32) | GLRA1SLC6A9OR51E2 | |
| SCHEMBL7175770 | 0.80 | GABRP (0.39) | GLRA1SLC6A9OR51E2ADRA1AGABRR1 | |
| SCHEMBL27647085 | 0.79 | GSR (0.52) | BLMPMP22ALOX15CYP1A2KMT2A | |
| SCHEMBL14836211 | 0.79 | GLRA1 (0.33) | GLRA1SLC6A9OR51E2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1021 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103483359-B | The preparation method of monovalence gold-mercaptan composite nano tube | CHONGQING UNIVERSITY (CN) | 2016-05-04 | — | — | CN | claimed |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-10-15 | — | — | US | claimed |
| EP-2925771-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | Council of Scientific & Industrial Research (IN) | 2015-10-07 | — | — | EP | claimed |
| CN-102119020-B | Hair treatment composition | KAO CORP. (JP) | 2014-10-08 | — | — | CN | claimed |
| WO-2014083578-A1 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESERACH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2014-06-05 | — | — | WO | claimed |
| CN-103483359-A | Method for preparing gold (I)-thiol composite nanotube | UNIV CHONGQING | 2014-01-01 | — | — | CN | claimed |
| CN-101820856-B | Non-oxidative hair dye composition | KAO CORP | 2013-01-02 | — | — | CN | claimed |
| CN-101820852-B | Hair dye composition | KAO CORP | 2012-06-13 | — | — | CN | claimed |
| WO-2012010851-A1 | CAPILLARY ELECTROPHORESIS OF CARBOHYDRATES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2012-01-26 | — | — | WO | claimed |
| CN-102119020-A | Hair treatment composition | KAO CORP | 2011-07-06 | — | — | CN | claimed |
| CN-1145365-A | Camptothecin derivatives | TANABE SEIYAKU CO (JP) | 1997-03-19 | — | — | CN | claimed |
| EP-0757049-A1 | Camptothecin derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1997-02-05 | — | — | EP | claimed |
| US-5582817-A | ORGANOZINC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-10 | — | — | US | claimed |
| US-5563644-A | Ink jet printing processes with microwave drying | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| EP-0559324-B1 | Ink jet printing processes with microwave drying | XEROX CORP (US) | 1995-10-18 | — | — | EP | claimed |
| EP-0583479-A1 | REMEDY FOR DERMATOPATHY AND METALLOTHIONEIN INDUCER | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-02-23 | — | — | EP | claimed |
| EP-0357784-B1 | A FEED COMPOSITION FOR CULTURING FISHES AND SHELLFISHES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-09-02 | — | — | EP | claimed |
| EP-0357784-A1 | A FEED COMPOSITION FOR CULTURING FISHES AND SHELLFISHES. | KYOWA HAKKO KOGYO KK (JP) | 1990-03-14 | — | — | EP | claimed |
| US-4883862-A | Mercaptosuccinyl glycyl-glycyl-glycine a complex thereof with Tc-99m, and methods of making the same | ALBERT EINSTEIN COLLEGE OF MEDICINE - OF YESHIVA UNIVERSITY (US) | 1989-11-28 | — | — | US | claimed |
| WO-1989006497-A1 | A FEED COMPOSITION FOR CULTURING FISHES AND SHELLFISHES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1989-07-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | CNR2, SRM, CNR1 | GLRA1 736/4885SLC6A9 2373/4885OR51E2 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.